Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Incardona

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
European Journal of Public Health|January 14, 2026
Mortality risk for healthcare workers and journalists in the Gaza Strip over 2023-24Francesca Incardona, Federica Bellerba, Sara Gandini, et al.
Yan Ke Xue Bao = Eye Science|March 24, 2007
Thrombospondin-1 expression in RPE and choroidal neovascular membranesShikun He, Francesca Incardona, Manlin Jin, et al.
Elife|June 19, 2015
Registered report: Interactions between cancer stem cells and their niche govern metastatic colonizationFrancesca Incardona, M Mehdi Doroudchi, Nawfal Ismail, et al.
Bioinformatics (Oxford, England)|November 4, 2008
Stochastic modelling of genotypic drug-resistance for human immunodeficiency virus towards long-term combination therapy optimizationMattia C F Prosperi, Roberto D'Autilia, Francesca Incardona, et al.
Molecular Cancer Therapeutics|September 3, 2011
A6 peptide activates CD44 adhesive activity, induces FAK and MEK phosphorylation, and inhibits the migration and metastasis of CD44-expressing cellsRandolph S Piotrowicz, Bassam B Damaj, Mohamed Hachicha, et al.
Clinical Case Reports|February 10, 2022
Pre-existing singleton E138A mutations in the reverse transcriptase gene do not affect the efficacy of first-line antiretroviral therapy regimens using rilpivirine in human immunodeficiency virus-infected patientsAnna Kuznetsova, Aleksey Lebedev, Konstantin Gromov, et al.
Plos One|June 6, 2017
Drug resistance testing through remote genotyping and predicted treatment options in human immunodeficiency virus type 1 infected Tanzanian subjects failing first or second line antiretroviral therapyJenny Svärd, Sabina Mugusi, Doreen Mloka, et al.
Tropical Medicine and Infectious Disease|May 26, 2023
Cohort Profile: A European Multidisciplinary Network for the Fight against HIV Drug Resistance (EuResist Network)Barbara Rossetti, Francesca Incardona, Giulia Di Teodoro, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2004
Characterization of defective CD4-CD8- T cells in murine tumors generated independent of antigen specificityRobert M Prins, Francesca Incardona, Regan Lau, et al.
Bioinformatics (Oxford, England)|May 22, 2024
Incorporating temporal dynamics of mutations to enhance the prediction capability of antiretroviral therapy's outcome for HIV-1Giulia Di Teodoro, Martin Pirkl, Francesca Incardona, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
European Journal of Public Health|January 14, 2026
Mortality risk for healthcare workers and journalists in the Gaza Strip over 2023-24Francesca Incardona, Federica Bellerba, Sara Gandini, et al.
Yan Ke Xue Bao = Eye Science|March 24, 2007
Thrombospondin-1 expression in RPE and choroidal neovascular membranesShikun He, Francesca Incardona, Manlin Jin, et al.
Elife|June 19, 2015
Registered report: Interactions between cancer stem cells and their niche govern metastatic colonizationFrancesca Incardona, M Mehdi Doroudchi, Nawfal Ismail, et al.
Bioinformatics (Oxford, England)|November 4, 2008
Stochastic modelling of genotypic drug-resistance for human immunodeficiency virus towards long-term combination therapy optimizationMattia C F Prosperi, Roberto D'Autilia, Francesca Incardona, et al.
Molecular Cancer Therapeutics|September 3, 2011
A6 peptide activates CD44 adhesive activity, induces FAK and MEK phosphorylation, and inhibits the migration and metastasis of CD44-expressing cellsRandolph S Piotrowicz, Bassam B Damaj, Mohamed Hachicha, et al.
Clinical Case Reports|February 10, 2022
Pre-existing singleton E138A mutations in the reverse transcriptase gene do not affect the efficacy of first-line antiretroviral therapy regimens using rilpivirine in human immunodeficiency virus-infected patientsAnna Kuznetsova, Aleksey Lebedev, Konstantin Gromov, et al.
Plos One|June 6, 2017
Drug resistance testing through remote genotyping and predicted treatment options in human immunodeficiency virus type 1 infected Tanzanian subjects failing first or second line antiretroviral therapyJenny Svärd, Sabina Mugusi, Doreen Mloka, et al.
Tropical Medicine and Infectious Disease|May 26, 2023
Cohort Profile: A European Multidisciplinary Network for the Fight against HIV Drug Resistance (EuResist Network)Barbara Rossetti, Francesca Incardona, Giulia Di Teodoro, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2004
Characterization of defective CD4-CD8- T cells in murine tumors generated independent of antigen specificityRobert M Prins, Francesca Incardona, Regan Lau, et al.
Bioinformatics (Oxford, England)|May 22, 2024
Incorporating temporal dynamics of mutations to enhance the prediction capability of antiretroviral therapy's outcome for HIV-1Giulia Di Teodoro, Martin Pirkl, Francesca Incardona, et al.
Pageof 5